// App-Quantinova.ai

P1-08-21 : Detection and monitoring of circulating endothelial cells, circulating tumor cells and disseminated tumor cells during neoadjuvant breast cancer treatment including bevacizumab

Researchers

Presenter

  • Mathiesen RR

Principal Investigators

  • Borgen E

  • Saetersdal AB

  • Fangberget A

  • Schirmer C

  • Stav I

  • Fagerland MW

  • Wist E

  • Engebraten O

  • Naume B

Medical Centers

  • Oslo University Hospital, Oslo, Norway

  • Oslo University Hospital, Oslo, Norway

  • Institute of Clinical Medicine, University of Oslo, OSLO, Norway

  • Oslo University Hospital - The Radiumhospital, Oslo, Norway

  • Norwegian Radium Hospital, Oslo University Hospital, Oslo, Norway

Locations

  • Norway

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Breast cancer

Biomarkers

  • Circulating endothelial cells

  • Circulating tumor cells

  • Human epidermal growth factor receptor 2

Drug/Treatment

  • Bevacizumab

  • Letrozole

  • taxane

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Final

Copyright © 2026. QuantiNova All rights reserved